[go: up one dir, main page]

RU2001117835A - Способ размола для получения тонкоизмельченных медицинских субстанций - Google Patents

Способ размола для получения тонкоизмельченных медицинских субстанций

Info

Publication number
RU2001117835A
RU2001117835A RU2001117835/14A RU2001117835A RU2001117835A RU 2001117835 A RU2001117835 A RU 2001117835A RU 2001117835/14 A RU2001117835/14 A RU 2001117835/14A RU 2001117835 A RU2001117835 A RU 2001117835A RU 2001117835 A RU2001117835 A RU 2001117835A
Authority
RU
Russia
Prior art keywords
product
less
grinded
crystalline substance
grinding method
Prior art date
Application number
RU2001117835/14A
Other languages
English (en)
Other versions
RU2219908C2 (ru
Inventor
Н. Мурти ВЕМУРИ
Эндрю Б. БРАУН
Жан-Рене Отелен
Патрик ХОСЕК
Original Assignee
Авентис Фарма Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9826284.3A external-priority patent/GB9826284D0/en
Application filed by Авентис Фарма Лимитед filed Critical Авентис Фарма Лимитед
Publication of RU2001117835A publication Critical patent/RU2001117835A/ru
Application granted granted Critical
Publication of RU2219908C2 publication Critical patent/RU2219908C2/ru

Links

Claims (12)

1. Способ получения тонкого высококристалличного вещества, заключающийся в распылительном размоле кристаллического вещества при относительной влажности, находящейся в интервале между 30 и 90%.
2. Способ по п. 1, где относительная влажность находится в интервале между 30 и 70%.
3. Способ по п. 1 или 2, где мельничной средой является воздух.
4. Способ по п. 1 или 2, где мельничной средой является азот.
5. Способ по любому из пп. 1-4, где кристаллическое вещество включает порошок медикамента.
6. Способ по п. 5, где кристаллическое вещество является ацетонидом триамцинолона.
7. Способ по п. 5, где кристаллическое вещество является сульфатом сальбутамола.
8. Способ по любому из пп. 1-7, где продукт имеет содержание аморфной фазы менее 5%.
9. Способ по п. 8, где продукт имеет содержание аморфной фазы менее 2%.
10. Способ по п. 9, где продукт имеет содержание аморфной фазы менее 1%.
11. Способ по любому из пп. 1-10, где продукт состоит из порошка медикамента в форме, пригодной для ингаляции.
12. Способ по п. 11, где продукт имеет средний размер частиц менее 10 мкм.
RU2001117835/15A 1998-12-01 1999-12-01 Способ размола для получения тонкоизмельченных медицинских субстанций RU2219908C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9826284.3A GB9826284D0 (en) 1998-12-01 1998-12-01 Process
GB9826284.3 1998-12-01

Publications (2)

Publication Number Publication Date
RU2001117835A true RU2001117835A (ru) 2003-03-27
RU2219908C2 RU2219908C2 (ru) 2003-12-27

Family

ID=10843360

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001117835/15A RU2219908C2 (ru) 1998-12-01 1999-12-01 Способ размола для получения тонкоизмельченных медицинских субстанций

Country Status (23)

Country Link
US (1) US6641063B2 (ru)
EP (1) EP1143928B1 (ru)
JP (1) JP4680389B2 (ru)
KR (1) KR100606319B1 (ru)
CN (1) CN1198583C (ru)
AT (1) ATE241958T1 (ru)
AU (1) AU763352B2 (ru)
BR (1) BR9916153B1 (ru)
CA (1) CA2352796C (ru)
CZ (1) CZ301914B6 (ru)
DE (1) DE69908650T2 (ru)
DK (1) DK1143928T3 (ru)
ES (1) ES2201842T3 (ru)
GB (1) GB9826284D0 (ru)
HU (1) HU224615B1 (ru)
IL (2) IL143344A0 (ru)
MX (1) MXPA01005472A (ru)
NO (1) NO20012677L (ru)
NZ (1) NZ512089A (ru)
PL (1) PL193800B1 (ru)
PT (1) PT1143928E (ru)
RU (1) RU2219908C2 (ru)
WO (1) WO2000032165A1 (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10204470C1 (de) * 2002-02-05 2003-08-14 Degussa Verfahren und Vorrichtung zur Herstellung von Dispersionen
DE10317461A1 (de) * 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
GB0409703D0 (en) * 2004-04-30 2004-06-02 Vectura Ltd Pharmaceutical compositions
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070191327A1 (en) * 2006-02-15 2007-08-16 Verus Pharmaceuticals, Inc. Sterilization of corticosteroids with reduced mass loss
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
WO2009016133A1 (en) * 2007-07-27 2009-02-05 Cargill, Incorporated Micronization of polyols
CN101618019B (zh) * 2008-07-01 2011-08-03 上海通用药业股份有限公司 一种醋酸曲安奈德微粒及其制备方法和药物组合物
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR20120015334A (ko) 2009-05-29 2012-02-21 펄 테라퓨틱스 인코포레이티드 활성제의 호흡기 전달용 조성물, 및 연관된 방법 및 시스템
JO3510B1 (ar) 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
DE102011102614A1 (de) * 2011-05-27 2012-11-29 Roland Nied Verfahren zum Betrieb einer Strahlmühle sowie Strahlmühle
DE102013000426A1 (de) * 2013-01-14 2014-07-17 Roland Nied Verfahren zur Strahlmahlung sowie Strahlmühle dafür
EP2968152B2 (en) * 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
MA50680A (fr) 2014-09-09 2020-08-05 Vectura Ltd Formulation comprenant glycopyrrolate, procédé et appareil
HUE050233T2 (hu) 2015-09-09 2020-11-30 Vectura Ltd Eljárás sugármalomhoz
CN106111304B (zh) * 2016-06-28 2018-05-22 山东大学齐鲁医院 营养补剂研磨加温装置
ES3009923T3 (en) 2017-03-15 2025-03-31 Vectura Ltd Method and formulation
CN115886107A (zh) * 2022-11-23 2023-04-04 杭州浙大百川生物食品技术有限公司 一种龙井干茶中香露提取方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937405A (en) * 1973-12-18 1976-02-10 Fluid Energy Processing And Equipment Company Apparatus for mixing pulverizing and grinding black powder
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
GB9226993D0 (en) * 1992-12-24 1993-02-17 Tioxide Group Services Ltd Method of simultaneous milling and drying
AUPM411494A0 (en) * 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5730795A (en) * 1996-09-24 1998-03-24 E. I. Du Pont De Nemours And Company Process for manufacturing titanium dioxide pigment having a hydrous oxide coating using a media mill
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
GB9808470D0 (en) * 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus

Similar Documents

Publication Publication Date Title
RU2001117835A (ru) Способ размола для получения тонкоизмельченных медицинских субстанций
CA2277913A1 (en) New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
KR970704422A (ko) 투여용 약제학적 조성물
EP0951917A3 (en) Particle delivery of particularly a powdered therapeutical agent
RU97102349A (ru) Композиция для получения лекарственного средства (варианты) и способ ее получения
EG21484A (en) Composition for inhalation
EP2011484A3 (en) Use of a dry powder composition of formoterol in the treatment of chronic obstructive pulmonary disease
EE04991B1 (et) Osake, ravimvorm, nende valmistamismeetodid, osakeste kasutamine ning farmatseutiline pakend
HK1038709A1 (zh) 製備結晶顆粒的設備和方法
CA2115065A1 (en) Ultrafine Particle Powder for Inhalation and Method for Production Thereof
CA2706634A1 (en) Preparation of powder agglomerates
CA2369722A1 (en) Powder inhaler for combined medicament
CA2302276A1 (en) Methods of treating capsules and dry, powdered pharmaceutical formulations
WO2001036015A3 (en) Powder inhaler
EA200100636A1 (ru) Усовершенствования порошков или связанные с порошками
AU6611998A (en) Therapeutic powder formulation for pulmonary administration, containing crystalline insulin
PL334493A1 (en) Novel inhalable preparation of 0.28 to 0.38 g/ml bulk density containing budesonide
HUP0104478A2 (hu) Őrlési eljárás finoman őrölt gyógyszerek előállítására
PL334528A1 (en) Novel inhalable preparation of 0.28 to 0.38 g/ml bulk density containing formotherol
MXPA02006518A (es) Aerosol de gota liquida de gamma -ifn y metodo.
AU6611898A (en) Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer
CA2287333A1 (en) Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
CA2277891A1 (en) New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
WO2002043693A3 (en) Pharmaceutical compositions for inhalation
AU660296B2 (en) Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same